Next report date
Report period
Q1 2024
EPS estimate
−0.42USD
Revenue estimate
1.99 MUSD
−444.04 MUSD
1.19 MUSD
220.71 M
Om Iovance Biotherapeutics, Inc.
Sektor
Bransch
VD
Frederick G. Vogt
Webbplats
Huvudkvarter
San Carlos
Employees (FY)
557
Grundat
2007
FIGI
BBG000FTLBV7
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
